PA8554901A1 - Esteres de analogos de 3-desoxi-vitamina d3 - Google Patents

Esteres de analogos de 3-desoxi-vitamina d3

Info

Publication number
PA8554901A1
PA8554901A1 PA20028554901A PA8554901A PA8554901A1 PA 8554901 A1 PA8554901 A1 PA 8554901A1 PA 20028554901 A PA20028554901 A PA 20028554901A PA 8554901 A PA8554901 A PA 8554901A PA 8554901 A1 PA8554901 A1 PA 8554901A1
Authority
PA
Panama
Prior art keywords
desoxi
steres
vitamin
analog
compounds
Prior art date
Application number
PA20028554901A
Other languages
English (en)
Inventor
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8554901A1 publication Critical patent/PA8554901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE ACUERDO CON LA FORMULA I O UNA SAL DEL MISMO, DONDE LA LINEA DE PUNTOS, R1, R2, R3, R4 Y L SON TAL COMO SE DEFINEN EN LAS REIVINDICACIONES. LA INVENCION ADEMAS SE REFIERE AL USO DE LOS COMPUESTOS DE FORMULA I O SALES DE LOS MISMOS COMO MEDICAMENTOS.
PA20028554901A 2001-09-21 2002-09-18 Esteres de analogos de 3-desoxi-vitamina d3 PA8554901A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32395701P 2001-09-21 2001-09-21
US32387001P 2001-09-21 2001-09-21

Publications (1)

Publication Number Publication Date
PA8554901A1 true PA8554901A1 (es) 2003-12-10

Family

ID=26984180

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028554901A PA8554901A1 (es) 2001-09-21 2002-09-18 Esteres de analogos de 3-desoxi-vitamina d3

Country Status (14)

Country Link
EP (1) EP1430026A1 (es)
JP (1) JP2005503434A (es)
KR (1) KR100628586B1 (es)
CN (1) CN1285573C (es)
AU (1) AU2002338672B2 (es)
BR (1) BR0212719A (es)
CA (1) CA2459789A1 (es)
MX (1) MXPA04002640A (es)
PA (1) PA8554901A1 (es)
PE (1) PE20030429A1 (es)
PL (1) PL370352A1 (es)
RU (1) RU2296121C2 (es)
UY (1) UY27448A1 (es)
WO (1) WO2003027065A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0315553A (pt) * 2002-10-23 2005-08-23 Leo Pharma As Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, método de tratamento ou profilaxia de hiperparatireoidismo secundário, e, uso de um composto, opcionalmente em conjunto com outro composto terapeuticamente ativo
JP2008514621A (ja) * 2004-09-24 2008-05-08 ビオクセル エッセ ピ ア ２０−シクロアルキル，２６，２７−アルキル／ハロアルキル−ビタミンｄ３化合物及びその使用方法
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
WO2010020966A2 (en) 2008-08-22 2010-02-25 Nxp B.V. Location-based services
CN110339205B (zh) * 2019-08-19 2021-08-24 山东德信生物科技有限公司 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
EP1015423B1 (en) * 1997-09-08 2003-05-02 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs

Also Published As

Publication number Publication date
EP1430026A1 (en) 2004-06-23
RU2296121C2 (ru) 2007-03-27
PL370352A1 (en) 2005-05-16
CA2459789A1 (en) 2003-04-03
WO2003027065A1 (en) 2003-04-03
BR0212719A (pt) 2004-08-03
MXPA04002640A (es) 2004-06-07
CN1556795A (zh) 2004-12-22
AU2002338672B2 (en) 2006-03-09
KR20040035853A (ko) 2004-04-29
CN1285573C (zh) 2006-11-22
RU2004112217A (ru) 2005-07-10
UY27448A1 (es) 2003-03-31
JP2005503434A (ja) 2005-02-03
KR100628586B1 (ko) 2006-09-26
PE20030429A1 (es) 2003-05-15

Similar Documents

Publication Publication Date Title
CR7042A (es) Indanil aminas aciladas y su uso como farmacos
CR8193A (es) Piperazina con o sustituida de grupos feniles y su uso como inhibidores de glyt 1
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
PA8551001A1 (es) Nuevos compuestos
UY26958A1 (es) Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación
ECSP056063A (es) 6-alquil o alquenil-4-aminopicolinatos y uso de los mismos como herbicidas
CR9777A (es) Derivados fungicidas de fenilamidina con piridiniloxi
UY26957A1 (es) Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación
PA8578601A1 (es) Derivados de 2,2- difenil-benzodioxol
GT200200085A (es) Derivados de oxazol
AR047352A1 (es) Analogos de rifamicina y los usos correspondientes
ECSP034444A (es) Derivados de 4-amino-6-fenil-pirrolo(2,3-d)pirimidina
CR9124A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas
ECSP045221A (es) Sales de valsartan
UY26721A1 (es) Nuevos derivados de la fenilglicina
CY1107485T1 (el) 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα
ECSP066278A (es) Pirimidinas 2-sustituidas
CR7758S (es) Barra de caramelo (paloma)
BRPI0519267A2 (pt) derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
UY28715A1 (es) Derivados de diarilmetil piperazina, sus preparaciones y sus usos
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones
UY26847A1 (es) Derivados de la pirrolidina
PA8554901A1 (es) Esteres de analogos de 3-desoxi-vitamina d3
UY26846A1 (es) Derivados de la pirrolidina